Skip to main content
S&P 5007,608.45+0.30%DOW51,975.40-0.23%NASDAQ26,155.26+0.67%BTC$75,506.00-1.21%ETH$2,387.22-2.55%GOLD$4,378.80+1.06%OIL$103.26-2.43%
Smart Investors Daily
CM

OTC · CMWAY

Commonwealth Bank of Australia

Financial Services · Banks - Diversified

$108.90

Down-$1.45 (-1.31%)

Updated Sep 16, 2026, 12:17 PM

SID Score

5.0/10

Composite research score

Smart Money

46/100

Neutral

Market cap
171.63B
P/E ratio
25.71
Dividend yield
2.86%
52-week range
$85.22 – $129.79
Volume
44.42K
Avg. volume
44.92K

Price performance

CMWAY price history

1M range · 0 trading sessions · Daily adjusted prices

CMWAY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CMWAY news

The latest Smart Investors Daily articles mentioning CMWAY.

Stock researchCompany · Overview

CMWAY research

Overview

Company profile and research snapshot.

Company profile

CMNWLTH BK AUSTRLA S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Sell
Average target
$130.18
Implied upside
—
Analysts
2
CMWAY recent ratings
DateFirmRatingTarget
Jul 7, 2026JEFFERIESUnderperform—
Jun 18, 2026MACQUARIE RESEARCHUnderperform—
Feb 25, 2026MACQUARIE RESEARCHUnderperform—
Feb 11, 2026JEFFERIESUnderperform—
Jan 26, 2026MACQUARIE RESEARCHUnderperform—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

Commonwealth Bank of Australia Stock Performance

Commonwealth Bank of Australia's ADR (CMWAY) trades at $108.90, reflecting a modest 1.2% decline over the past month but a robust 16.25% gain over the trailing three-month period, per SID market data. On a twelve-month basis, the stock has delivered a 31.0% return, significantly outperforming broader financial sector benchmarks. Despite the longer-term strength, the stock currently trades below both its 50-day moving average of $113.89 and its 200-day moving average of $111.96, indicating near-term technical weakness. The 14-day RSI stands at 34.9, approaching oversold territory and suggesting recent selling pressure has been pronounced. CMWAY carries a beta of 0.892, according to Massive/Polygon data, reflecting lower volatility relative to the broader market. Average daily volume remains relatively thin at approximately 44,920 shares, consistent with its status as a foreign-listed ADR on U.S. exchanges.

Commonwealth Bank of Australia Valuation Analysis

Commonwealth Bank of Australia currently commands a market capitalization of approximately $171.6 billion, making it one of the most valuable financial institutions globally. Per SID market data, the stock trades at a price-to-earnings ratio of 25.71, a premium valuation relative to many global banking peers, which typically trade in the low-to-mid teens. The price-to-book ratio stands at 3.30, per SEC filings, further underscoring the elevated premium investors assign to the company's earnings stability and Australian market dominance. The PEG ratio of 38.69 suggests that the current earnings multiple substantially exceeds the company's expected earnings growth rate, indicating limited growth-adjusted value at present levels. The trailing dividend yield sits at 3.12%, which remains attractive for income-oriented investors but is below the historical average for large-cap Australian banks. These valuation metrics collectively position CMWAY at the upper end of the global banking valuation spectrum within the financial services sector.

Smart Money Activity for CMWAY

Smart money indicators for Commonwealth Bank of Australia reflect a broadly neutral posture among sophisticated market participants. The composite smart money score stands at 46 out of 100, generating a neutral signal according to SID market data. Breaking down the sub-components, insider activity scores 12.5 out of 25, suggesting neither aggressive accumulation nor notable distribution by corporate insiders, per SEC Form 4 filings. Institutional positioning registers at 13.0 out of 25, indicating moderate but unremarkable interest from large fund managers tracked through 13F institutional filings. Dark pool activity scores a relatively low 8.5 out of 25, pointing to limited off-exchange block trading activity, which may partly reflect the stock's ADR structure and comparatively thin U.S. trading volume. Congressional trading activity scores 12 out of 25, showing no significant legislative interest. The absence of strong directional conviction across all four smart money categories suggests institutional participants are maintaining existing positions without meaningful new commitments in either direction at current price levels.

Commonwealth Bank of Australia Earnings Outlook

Commonwealth Bank of Australia has demonstrated consistent earnings delivery over the past four reporting periods, per company earnings reports. In the most recent quarter ending June 30, 2025, the bank reported EPS of $3.058, marginally missing the consensus estimate of $3.080 by $0.022, representing its first negative earnings surprise in at least four quarters. The prior quarter ending December 31, 2024, saw EPS of $3.065 against an estimate of $3.033, a positive surprise of $0.032. The June 2024 and December 2023 quarters similarly delivered upside surprises of $0.025 and $0.064, respectively, according to analyst estimates. Notably, earnings have ranged between $2.865 and $3.065 over the trailing four quarters, reflecting relative stability in the bank's core profitability. The slight miss in the latest period warrants monitoring, as it marks a potential inflection following three consecutive beats, though the deviation from consensus remained minimal in absolute terms.

Wall Street Analyst Ratings for CMWAY

Wall Street analyst sentiment toward Commonwealth Bank of Australia remains decidedly bearish, according to SID consensus data. The most recent coverage updates show uniformly negative ratings, with Jefferies reiterating an Underperform rating on July 7, 2026, maintaining its prior Underperform stance. Macquarie Research has similarly reiterated its Underperform rating across three separate updates dated June 18, February 25, and January 26, 2026, per Wall Street analyst reports. The consistent Underperform ratings from both Jefferies and Macquarie reflect a view that the stock's elevated valuation—currently trading at a 25.71 P/E multiple—leaves limited upside potential relative to the bank's growth profile. No upgrades or neutral ratings appear in the recent coverage history, making CMWAY one of the more consensus-bearish names among large-cap global banks. The lack of any dissenting bullish view among covering analysts is notable, as it suggests a broadly shared concern about the disconnect between the stock's premium pricing and its fundamental earnings trajectory.

Featured By